|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM207263981 |
003 |
DE-627 |
005 |
20231224001716.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2011 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2011.03.012
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0691.xml
|
035 |
|
|
|a (DE-627)NLM207263981
|
035 |
|
|
|a (NLM)21470915
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Quigg, Richard J
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a If oxidized LDL immune complexes are relevant in diabetic atherosclerosis, shouldn't they also be relevant in diabetic nephropathy?
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 08.08.2011
|
500 |
|
|
|a Date Revised 17.05.2011
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a CommentOn: Clin Immunol. 2011 Jun;139(3):258-66. - PMID 21439910
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Comment
|
650 |
|
4 |
|a Editorial
|
650 |
|
7 |
|a Antigen-Antibody Complex
|2 NLM
|
650 |
|
7 |
|a Lipoproteins, LDL
|2 NLM
|
650 |
|
7 |
|a oxidized low density lipoprotein
|2 NLM
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 139(2011), 3 vom: 01. Juni, Seite 233-4
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:139
|g year:2011
|g number:3
|g day:01
|g month:06
|g pages:233-4
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2011.03.012
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 139
|j 2011
|e 3
|b 01
|c 06
|h 233-4
|